These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27209093)

  • 1. Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.
    Bernelot Moens SJ; van der Valk FM; Strang AC; Kroon J; Smits LP; Kneepkens EL; Verberne HJ; van Buul JD; Nurmohamed MT; Stroes ES
    Arthritis Res Ther; 2016 May; 18(1):115. PubMed ID: 27209093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis.
    Agca R; Blanken AB; van Sijl AM; Smulders YM; Voskuyl AE; van der Laken C; Boellaard R; Nurmohamed MT
    Rheumatology (Oxford); 2021 Jul; 60(7):3360-3368. PubMed ID: 33447846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
    Amigues I; Tugcu A; Russo C; Giles JT; Morgenstein R; Zartoshti A; Schulze C; Flores R; Bokhari S; Bathon JM
    Arthritis Rheumatol; 2019 Apr; 71(4):496-506. PubMed ID: 30407745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment.
    Blanken AB; Agca R; van Sijl AM; Voskuyl AE; Boellaard R; Smulders YM; van der Laken CJ; Nurmohamed MT
    Semin Arthritis Rheum; 2021 Apr; 51(2):457-463. PubMed ID: 33770536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial Inflammation Detected With
    Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
    Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
    Trang DAMT; Okamura K; Suto T; Sakane H; Yonemoto Y; Nakajima T; Tsushima Y; Chikuda H
    Arthritis Res Ther; 2021 Aug; 23(1):206. PubMed ID: 34344436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study.
    Linde A; Gerdts E; Fevang BT; Eilertsen RK; Kringeland E; Alsing CL; Midtbø H
    Blood Press; 2024 May; 33(1):2353167. PubMed ID: 38824646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils of rheumatoid arthritis patients on anti-TNF-α therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels.
    Dominical VM; Bértolo MB; Almeida CB; Garrido VT; Miguel LI; Costa FF; Conran N
    Scand J Immunol; 2011 Apr; 73(4):309-18. PubMed ID: 21208248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial and Cellular Inflammation in Patients with CKD.
    Bernelot Moens SJ; Verweij SL; van der Valk FM; van Capelleveen JC; Kroon J; Versloot M; Verberne HJ; Marquering HA; Duivenvoorden R; Vogt L; Stroes ES
    J Am Soc Nephrol; 2017 Apr; 28(4):1278-1285. PubMed ID: 27799487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
    Forslind K; Svensson B
    Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis.
    Haavisto M; Saraste A; Pirilä L; Hannukainen JC; Kalliokoski KK; Kirjavainen A; Kemppainen J; Möttönen T; Knuuti J; Yli-Kerttula T; Roivainen A
    Rheumatology (Oxford); 2016 Oct; 55(10):1777-85. PubMed ID: 27330160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.
    Vázquez I; Graell E; Gratacós J; Cañete JD; Viñas O; Ercilla MG; Gómez A; Hernández MV; Rodríguez-Cros JR; Larrosa M; Sanmartí R
    Clin Exp Rheumatol; 2007; 25(2):231-8. PubMed ID: 17543147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans.
    Bernelot Moens SJ; Verweij SL; Schnitzler JG; Stiekema LCA; Bos M; Langsted A; Kuijk C; Bekkering S; Voermans C; Verberne HJ; Nordestgaard BG; Stroes ESG; Kroon J
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):969-975. PubMed ID: 28336558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.
    Brenol CV; da Chakr RM; Andrade NP; Toni M; Laurindo IM; Brenol JC; Xavier RM
    Clin Rheumatol; 2015 Oct; 34(10):1781-5. PubMed ID: 25771853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.